SEARCH

SEARCH BY CITATION

References

  • 1
    Vail DM, Young KM. Canine lymphoma and lymphoid leukemias. In: WithrowSJ, VailDM, eds. Withrow & MacEwen's Small Animal Clinical Oncology, 4th ed. St Louis, MO: Saunders Elsevier; 2007:699733.
  • 2
    Bergman PJ, Ogilvie GK, Powers BE. Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: Seqential analysis and predictive ability in dogs with lymphoma. J Vet Intern Med 1996;10:354359.
  • 3
    Less JJ, Hughes CS, Fine RL, et al. P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance. Cancer 1996;77:18921898.
  • 4
    Moore AS, Leveille CR, Reimann KA, et al. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest 1995;13:475479.
  • 5
    Tew KD, Coluin OM, Jones RB. Clinical and high-dose alkylating agents. In: ChabnerBA, LongoDL, eds. Cancer Chemotherapy and Biotherapy, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:283309.
  • 6
    Cole SPC, Tannock IF. Drug resistance. In: TannokIF, HillRP, BristowRG, HarringtonL, eds. The Basic Science of Oncology, 4th ed. New York: McGraw-Hill Medical Publishing Division; 2005:376399.
  • 7
    Moore AS, London CA, Wood CA, et al. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13:395398.
  • 8
    Rassnick KM, Mauldin GE, Al-Sarraf R, et al. MOPP chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989–2000). J Vet Intern Med 2002;16:576580.
  • 9
    Flory AB, Rassnick KM, Al-Sarraf R, et al. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. J Vet Intern Med 2008;22:164171.
  • 10
    Saba CF, Thamm DH, Vail DM. Combination chemotherapy with l-asparaginase, lomustine, and prednisone for relapsed or refractory lymphoma. J Vet Intern Med 2007;21:127132.
  • 11
    Rogers KS. l-asparaginase for treatment of lymphoid neoplasia in dogs. J Am Vet Med Assoc 1989;194:16261630.
  • 12
    Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704709.
  • 13
    Chabner BA, Friedmann AM. Asparaginase. In: ChabnerBA, LongoDL, eds. Cancer Chemotherapy and Biotherapy, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:476483.
  • 14
    Copur MS, Rose MG, Chu E. Miscellaneous chemotherapeutic agents. In: DeVitaVT, HellmanS, RosenbergSA, eds. Cancer, Principles & Practice of Oncology, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:416422.
  • 15
    MacDonald VS, Thamm DH, Kurzman ID, et al. Does l-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma? J Vet Intern Med 2005;19:732736.
  • 16
    Jeffreys AB, Knapp DW, Carlton WW, et al. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. J Am An Hosp Assoc 2005;41:221226.
  • 17
    Veterinary Co-operative Oncology Group. Veterinary co-operative oncology group common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Compar Oncol 2004;2:194213.
  • 18
    Chu E, DeVita VT. Principles of medical oncology. In: DeVitaVT, HellmanS, RosenbergSA, eds. Cancer, Principles & Practice of Oncology, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:295306.
  • 19
    Boyce KL, Kitchell BE. Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 2000;36:395403.
  • 20
    Moore AS, Cotter SM, Rand WM, et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15:348354.
  • 21
    Carter SK, Newman JW. Nitrosoureas: 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)—Clinical brochure. Cancer Chemother Rep (Part 3) 1968;1:115151.
  • 22
    Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 1999;13:601605.
  • 23
    Kristal O, Rassnick KM, Gliatto JM, et al. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 2004;18:7580.